Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 0.16 is 157% above its 5-year average of -0.28, near the high end of its 5-year range (-0.72–0.16).
173.50% above its 12-month average of 0.06.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): 0.11.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T18:22:17.213Z. Historical observations retain their original dates. Historical series through 2026-10-05.
EARNINGS PER SHARE (EPS)
0.16
EARNINGS PER SHARE (EPS) AVG TTM
0.06
EARNINGS PER SHARE (EPS) AVG 3Y
-0.19
EARNINGS PER SHARE (EPS) AVG 5Y
-0.28
EARNINGS PER SHARE (EPS) AVG 10Y
-0.37
EARNINGS PER SHARE (EPS) AVG 15Y
-0.94
EARNINGS PER SHARE (EPS) AVG 20Y
-1.88
CURRENT VS TTM AVG
+173.50%
CURRENT VS 3Y AVG
+184.99%
CURRENT VS 5Y AVG
+157.04%
CURRENT VS 10Y AVG
+142.90%
CURRENT VS 15Y AVG
+117.02%
CURRENT VS 20Y AVG
+108.50%
Nephros, Inc.
Market Cap
$37.89M
Earnings Per Share (EPS)
0.16
TTM Avg
0.06
3Y Avg
-0.19
5Y Avg
-0.28
Market Cap
$37.94M
Earnings Per Share (EPS)
N/A
TTM Avg
-21.23
3Y Avg
-13.85
5Y Avg
-9.58
Market Cap
$38.81M
Earnings Per Share (EPS)
-2.33
TTM Avg
-7.80
3Y Avg
-4.68
5Y Avg
-3.46
Market Cap
$39.06M
Earnings Per Share (EPS)
-2.49
TTM Avg
-2.22
3Y Avg
-1.86
5Y Avg
-2.21
Market Cap
$36.70M
Earnings Per Share (EPS)
-1.69
TTM Avg
-1.60
3Y Avg
-3.62
5Y Avg
-4.57
Market Cap
$36.51M
Earnings Per Share (EPS)
-2.13
TTM Avg
-3.42
3Y Avg
-5.72
5Y Avg
-5.72
Market Cap
$36.28M
Earnings Per Share (EPS)
-1.17
TTM Avg
-1.36
3Y Avg
-0.92
5Y Avg
-0.84
Market Cap
$35.69M
Earnings Per Share (EPS)
-2.56
TTM Avg
-5.45
3Y Avg
-15.27
5Y Avg
-9.79
Market Cap
$40.54M
Earnings Per Share (EPS)
-0.87
TTM Avg
-1.21
3Y Avg
-1.66
5Y Avg
-1.49
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Nephros, Inc. (NEPH) | $37.89M | 0.16 | 0.06 | -0.19 | -0.28 |
| Incannex Healthcare Limited (IXHL)vs › | $37.94M | N/A | -21.23 | -13.85 | -9.58 |
| Harvard Bioscience, Inc. (HBIO)vs › | $38.81M | -2.33 | -7.80 | -4.68 | -3.46 |
| Metagenomi, Inc. Common Stock (MGX)vs › | $39.06M | -2.49 | -2.22 | -1.86 | -2.21 |
| Edesa Biotech, Inc. (EDSA)vs › | $36.70M | -1.69 | -1.60 | -3.62 | -4.57 |
| Elicio Therapeutics, Inc. (ELTX)vs › | $36.51M | -2.13 | -3.42 | -5.72 | -5.72 |
| QT Imaging Holdings, Inc. (QTI)vs › | $36.28M | -1.17 | -1.36 | -0.92 | -0.84 |
| EUDA Health Holdings Limited (EUDA)vs › | $35.69M | -2.56 | -5.45 | -15.27 | -9.79 |
| Filana Therapeutics, Inc. (FLNA)vs › | $40.54M | -0.87 | -1.21 | -1.66 | -1.49 |
| DocGo Inc. (DCGO)vs › | $35.57M | -1.96 | -0.82 | -0.31 | -0.18 |
Trailing EPS (TTM)
$0.16
Forward EPS (Est.)
$0.16
P/E Ratio
22.0
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | 0.11 |
| 2024-12-31 | 0.01 |
| 2023-12-31 | -0.15 |
| 2022-12-31 | -0.72 |
| 2021-12-31 | -0.41 |
| 2020-12-31 | -0.52 |
| 2019-12-31 | -0.42 |
| 2018-12-31 | -0.50 |
| 2017-12-31 | -0.14 |
| 2016-12-31 | -0.56 |
| 2015-12-31 | -0.80 |
| 2014-12-31 | -2.79 |
| 2013-12-31 | -2.13 |
| 2012-12-31 | -2.62 |
| 2011-12-31 | -2.46 |
| 2010-12-31 | -8.34 |
| 2009-12-31 | -9.54 |
| 2008-12-31 | -29.89 |
| 2007-12-31 | -303.21 |
| 2006-12-31 | -117.10 |
| 2005-12-31 | -80.22 |
| 2004-12-31 | -309.91 |
| 2003-12-31 | -636.62 |
| 2002-12-31 | -273.02 |
| 2001-12-31 | -122.70 |
